Greater Cannabis Company (GCAN) Invested Capital (2016 - 2022)
Greater Cannabis Company's (GCAN) quarterly Invested Capital came in at $260000.0 in Q4 2022, little changed year-on-year from $260000.0 in Q4 2021, and little changed quarter-over-quarter from $260000.0 in Q3 2022.
Greater Cannabis Company (GCAN) Invested Capital (2016 - 2022) Analysis & Trends
Greater Cannabis Company's Invested Capital history runs 7 years deep, the most recent figure standing at $260000.0 for Q4 2022.
- On a quarterly basis, Invested Capital changed 0.0% year-over-year to $260000.0 in Q4 2022; TTM through Sep 2023 was $260000.0, a 75.0% decrease from a year earlier, with the FY2022 full-year figure at $260000.0, changed 0.0% from the prior year.
- Invested Capital held at $260000.0 in Q4 2022 per GCAN's latest filing, from $260000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $260000.0 in Q3 2018 and bottomed at $12245.0 in Q1 2018.
- The 5-year median for Invested Capital is $260000.0 (2018), against an average of $235577.2.
- Across the five-year window, Invested Capital surged 5870.15% in 2018 and changed 0.0% in 2019, its largest moves.
- Year by year, Invested Capital stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then changed by 0.0% to $260000.0 in 2020, then changed by 0.0% to $260000.0 in 2021, then changed by 0.0% to $260000.0 in 2022.
- Per Business Quant, the three latest GCAN Invested Capital figures stand at $260000.0 (Q4 2022), $260000.0 (Q3 2022), and $260000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 260,000.00 |
| Sep 30, 2022 | 260,000.00 |
| Jun 30, 2022 | 260,000.00 |
| Mar 31, 2022 | 260,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 260,000.00 |
| Jun 30, 2021 | 260,000.00 |
| Mar 31, 2021 | 260,000.00 |
| Dec 31, 2020 | 260,000.00 |
| Sep 30, 2020 | 260,000.00 |
| Jun 30, 2020 | 260,000.00 |
| Mar 31, 2020 | 260,000.00 |
| Dec 31, 2019 | 260,000.00 |
| Sep 30, 2019 | 260,000.00 |
| Jun 30, 2019 | 260,000.00 |
| Mar 31, 2019 | 260,000.00 |
| Dec 31, 2018 | 260,000.00 |
| Sep 30, 2018 | 260,000.00 |
| Jun 30, 2018 | 19,299.00 |
| Mar 31, 2018 | 12,245.00 |